Tuberculosis in Siberia: 2. Diagnosis, chemoprophylaxis and treatment

Tuber Lung Dis. 1996 Aug;77(4):297-301. doi: 10.1016/s0962-8479(96)90092-1.

Abstract

Objective: To assess tuberculosis diagnosis, chemoprophylaxis and therapy in Siberia as a paradigm for the Russian Federation.

Design: Data was obtained from official sources and through visits to dispensaries and hospitals in 1994.

Results: Tuberculosis disease and cure is classified according to a Dispensary Group Register based principally on clinical and radiological criteria. Isoniazid is widely used for chemoprophylaxis and post-therapy and may be linked to high levels of isoniazid resistance. Combination drug therapy is individualized, frequently changed, and given orally, parenterally or intra-bronchially. Galvanization, autotransfusion of ultra-violet irradiated blood, antioxidants and steroids are used as adjunct treatment. Ambulatory treatment is uncommon. Surgical treatments including lobectomy and pneumonectomy are used in 5-10% of patients.

Conclusion: Tuberculosis is increasing in Siberia. An improved drug supply using short course standardized regimens is required supported by high quality co-ordinated bacteriological services. Surgery retains a useful role, but many adjunct therapies should be abandoned.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antitubercular Agents / administration & dosage
  • Antitubercular Agents / supply & distribution
  • Antitubercular Agents / therapeutic use
  • Child
  • Drug Therapy, Combination
  • Humans
  • Isoniazid / therapeutic use
  • Pneumonectomy
  • Radiography
  • Siberia
  • Tuberculosis / diagnosis
  • Tuberculosis / drug therapy
  • Tuberculosis / therapy*
  • Tuberculosis, Pulmonary / diagnostic imaging
  • Tuberculosis, Pulmonary / prevention & control

Substances

  • Antitubercular Agents
  • Isoniazid